| Participation of p53 cellular tumour antigen in transformation of normal embryonic cells D Eliyahu, A Raz, P Gruss, D Givol, M Oren Nature 312 (5995), 646-649, 1984 | 1098 | 1984 |
| Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family S Akahani, P Nangia-Makker, H Inohara, HRC Kim, A Raz Cancer research 57 (23), 5272-5276, 1997 | 676 | 1997 |
| Galectin-3 induces endothelial cell morphogenesis and angiogenesis P Nangia-Makker, Y Honjo, R Sarvis, S Akahani, V Hogan, KJ Pienta, ... The American journal of pathology 156 (3), 899-909, 2000 | 657 | 2000 |
| Murine models to evaluate novel and conventional therapeutic strategies for cancer JE Talmadge, RK Singh, IJ Fidler, A Raz The American journal of pathology 170 (3), 793-804, 2007 | 619 | 2007 |
| Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin P Nangia-Makker, V Hogan, Y Honjo, S Baccarini, L Tait, R Bresalier, ... Journal of the National Cancer Institute 94 (24), 1854-1862, 2002 | 604 | 2002 |
| CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis T Fukumori, Y Takenaka, T Yoshii, HRC Kim, V Hogan, H Inohara, ... Cancer research 63 (23), 8302-8311, 2003 | 495 | 2003 |
| Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis A Raz, R Lotan Cancer and Metastasis Reviews 6, 433-452, 1987 | 453 | 1987 |
| Galectin-3 and metastasis Y Takenaka, T Fukumori, A Raz Glycoconjugate journal 19, 543-549, 2002 | 445 | 2002 |
| Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin KJ Pienta, H Nailk, A Akhtar, K Yamazaki, TS Replogle, J Lehr, TL Donat, ... JNCI: Journal of the National Cancer Institute 87 (5), 348-353, 1995 | 441 | 1995 |
| Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria: a role for synexin in galectin-3 translocation F Yu, RL Finley, A Raz, HRC Kim Journal of Biological Chemistry 277 (18), 15819-15827, 2002 | 436 | 2002 |
| On the role of galectin-3 in cancer apoptosis S Nakahara, N Oka, A Raz Apoptosis 10, 267-275, 2005 | 422 | 2005 |
| Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells HRC Kim, HM Lin, H Biliran, A Raz Cancer research 59 (16), 4148-4154, 1999 | 421 | 1999 |
| Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery G Poste, C Bucana, A Raz, P Bugelski, R Kirsh, IJ Fidler Cancer research 42 (4), 1412-1422, 1982 | 404 | 1982 |
| On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis E Gorelik, U Galili, A Raz Cancer and Metastasis Reviews 20, 245-277, 2001 | 389 | 2001 |
| Modified citrus pectin anti-metastatic properties: one bullet, multiple targets VV Glinsky, A Raz Carbohydrate research 344 (14), 1788-1791, 2009 | 368 | 2009 |
| Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest T Yoshii, T Fukumori, Y Honjo, H Inohara, HRC Kim, A Raz Journal of biological chemistry 277 (9), 6852-6857, 2002 | 365 | 2002 |
| Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion H Inohara, S Akahani, K Koths, A Raz Cancer research 56 (19), 4530-4534, 1996 | 364 | 1996 |
| Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and-9 J Ochieng, R Fridman, P Nangia-Makker, DE Kleiner, LA Liotta, ... Biochemistry 33 (47), 14109-14114, 1994 | 353 | 1994 |
| Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide H Watanabe, K Takehana, M Date, T Shinozaki, A Raz Cancer research 56 (13), 2960-2963, 1996 | 337 | 1996 |
| Proteases, extracellular matrix, and cancer: a workshop of the path B study section YA DeClerck, AM Mercurio, MS Stack, HA Chapman, MM Zutter, ... The American journal of pathology 164 (4), 1131-1139, 2004 | 320 | 2004 |
